HeartFlow plans a $100M IPO to fund R&D and new products despite financial risks. Read about its prospects, challenges, and ...

A surge in IPOs can sometimes indicate companies are rushing to capitalize on favorable conditions before a potential market ...

Heartflow Holding Inc. is aiming to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a merger with Longview Acquisition Corp.

Heartflow Holding Inc. is aiming to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a merger with Longview Acquisition Corp.